Rutin’s cardioprotective promise: a systematic review of mechanisms and efficacy in non-clinical chemotoxicity models
Year: 2026
Type: article
Study design: Systematic Review
Abstract: Chemotherapy remains a crucial part of cancer treatment, markedly alleviating the societal burden of the disease. Nonetheless, the advantageous therapeutic effects of these drugs are generally accompanied by significant unfavorable consequences, including damage to healthy tissues, with heart toxicity being a primary concern. Rutin, a phyto-antioxidant, has considerable potential to regulate disorders associated with oxidative stress, inflammation, and apoptosis. This review systematically evaluates the efficacy of rutin in protecting the heart against injury induced by chemotherapeutic agents. In this study, the search terms were selected based on the research purpose and used to examine the titles and abstracts of papers. After a comprehensive examination of the literature in databases (PubMed, ISI, and Scopus) up to December 2025, adhering to PRISMA guidelines, 193 papers were evaluated, and 14 studies were chosen based on established inclusion and exclusion criteria. Data analysis revealed that many categories of chemotherapeutic drugs induce detrimental cardiac side effects in both in vitro and in vivo models. Co-treatment with rutin significantly reversed detrimental changes and maintained heart function and physiological parameters. The preventive properties of rutin primarily stem from its ability to reduce oxidative stress, downregulate inflammatory pathways, and prevent cell death. Although preliminary findings from animal studies suggest potential benefits of co-administering rutin with chemotherapy, additional clinical trials are necessary to determine whether rutin may compromise the efficacy of chemotherapeutic agents and to evaluate its safety and effectiveness as a cardioprotective supplement for cancer patients.
Source: BMC Cancer
Language: English
Subfield: Cardiology and Cardiovascular Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $3,390
Award: G9001397035
OpenAlex ID: W7235961217
